The infant of a mother with diabetes is hypoglycemic. What type of feeding should be instituted first?

Choice a) They are born before 38 weeks of gestation is incorrect because this is not the definition of SGA. SGA refers to newborns who have a birth weight or length that is significantly lower than expected for their gestational age, regardless of when they are born. Therefore, a newborn can be SGA even if they are born at term or post-term.

Choice b) Placental malfunction is the only recognized cause of this condition is incorrect because this is not the only factor that can contribute to SGA. Placental malfunction can cause fetal growth restriction due to insufficient blood supply and nutrients to the fetus, but there are other possible causes such as maternal factors (e.g.,

hypertension, diabetes, smoking, malnutrition), fetal factors (e.g., chromosomal abnormalities, infections, congenital anomalies), and environmental factors (e.g., altitude, pollution, stress).

Choice c) They weigh less than 2500 g is incorrect because this is not the criterion for SGA. SGA is based on the comparison of the newborn's weight or length with the expected values for their gestational age, not on an absolute cutoff. Therefore, a newborn can be SGA even if they weigh more than 2500 g, as long as they are below the 10th percentile for their gestational age.

Choice d) They are below the 10th percentile on gestational growth charts is correct because this is the most commonly used definition of SGA. Gestational growth charts are tools that plot the expected weight or length of a fetus or newborn according to their gestational age and sex. They are based on population data and can vary

depending on the ethnicity and region of origin of the mother and the baby. A newborn who falls below the 10th percentile on these charts is considered SGA, meaning that they have grown less than 90% of their peers .

Choice a) Consult the physician, because the dose is too high is incorrect because this is not a necessary or appropriate action for a nurse who is following a valid order for betamethasone. Betamethasone is a corticosteroid that can be used to accelerate fetal lung maturation and reduce the risk of respiratory distress syndrome and other complications in preterm infants. The recommended dose for betamethasone is 12 mg IM every 24 hours for two doses, which is exactly what the physician ordered. Therefore, there is no reason to question or consult the physician about the dose, as it is within the normal range and based on evidence-based practice.

Choice b) Schedule the second dose for 11 am on the next day is incorrect because this is not a correct or accurate way to implement the order for betamethasone. Betamethasone should be given at least 24 hours apart, but not more than 48 hours apart, to achieve optimal fetal lung development and neonatal outcomes. Scheduling the second dose for 11 am on the next day would result in a 24-hour interval between the doses, which is acceptable, but not ideal. The best time to schedule the second dose would be between 24 and 48 hours after the first dose, such as at 11 pm on the same day or at 7 am on the next day.

Choice c) Prepare to administer the medication intramuscularly between contractions is correct because this is the best and most appropriate way to implement the order for betamethasone. Betamethasone should be given by intramuscular injection in a large muscle mass, such as the deltoid or gluteus, using a 21-gauge needle and a syringe with an air lock. The injection site should be cleaned with alcohol and aspirated before injecting. The medication should be administered between contractions, when the uterine blood flow is maximal and the fetal absorption is optimal. The nurse should also monitor the woman and the fetus for any adverse effects of betamethasone, such as maternal hyperglycemia, hypertension, infection, or edema, or fetal tachycardia, hypoglycemia, or infection.

Choice d) Explain to the woman that this medication will reduce her heart rate and help her to breathe easier is incorrect because this is not a true or relevant statement about betamethasone. Betamethasone does not have any direct effect on the maternal heart rate or respiratory function, as it is mainly intended to improve the fetal lung maturation and reduce the risk of respiratory distress syndrome and other complications in preterm infants.

Betamethasone may cause some side effects such as increased blood pressure, blood sugar, or fluid retention in the mother, which may affect her cardiovascular or respiratory status indirectly. However, these effects are usually transient and mild, and do not outweigh the benefits of betamethasone for the fetus. Therefore, this statement is misleading and inaccurate.